Onkologie. 2016:10(3):142-145 | DOI: 10.36290/xon.2016.031
A treatment of breast cancer is undergoing important advances for last years, which lead to improvement of the prognosis and
to extension their overall survival. Two new drugs (pertuzumab and trastuzumab emtansin) have been classified into a practice
for patients with advanced HER2 positive breast tumor. Experiences from the clinical practice confirmed the safety of both preparations
and the profit for the patients.
Published: June 1, 2016 Show citation